nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—obesity—polycystic ovary syndrome	0.849	1	CtDrD
Topiramate—GRIA3—adrenal cortex—polycystic ovary syndrome	0.00232	0.0617	CbGeAlD
Topiramate—GRIK5—pituitary gland—polycystic ovary syndrome	0.00213	0.0565	CbGeAlD
Topiramate—GRIK3—pituitary gland—polycystic ovary syndrome	0.00213	0.0565	CbGeAlD
Topiramate—GRIK5—adrenal gland—polycystic ovary syndrome	0.0019	0.0504	CbGeAlD
Topiramate—GRIK3—adrenal gland—polycystic ovary syndrome	0.0019	0.0504	CbGeAlD
Topiramate—GRIK3—vagina—polycystic ovary syndrome	0.00176	0.0467	CbGeAlD
Topiramate—CYP2C19—urine—polycystic ovary syndrome	0.00176	0.0467	CbGeAlD
Topiramate—GRIK1—female gonad—polycystic ovary syndrome	0.00168	0.0447	CbGeAlD
Topiramate—GRIA3—adrenal gland—polycystic ovary syndrome	0.00168	0.0446	CbGeAlD
Topiramate—GRIK1—vagina—polycystic ovary syndrome	0.00167	0.0444	CbGeAlD
Topiramate—GRIK1—endocrine gland—polycystic ovary syndrome	0.00156	0.0416	CbGeAlD
Topiramate—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00145	0.037	CcSEcCtD
Topiramate—Acidosis—Metformin—polycystic ovary syndrome	0.00138	0.0351	CcSEcCtD
Topiramate—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00136	0.0347	CcSEcCtD
Topiramate—Hypothermia—Metformin—polycystic ovary syndrome	0.00136	0.0347	CcSEcCtD
Topiramate—Toothache—Metformin—polycystic ovary syndrome	0.00126	0.032	CcSEcCtD
Topiramate—CA5A—endocrine gland—polycystic ovary syndrome	0.00121	0.032	CbGeAlD
Topiramate—GRIA2—embryo—polycystic ovary syndrome	0.0012	0.0319	CbGeAlD
Topiramate—Nail disorder—Metformin—polycystic ovary syndrome	0.00118	0.03	CcSEcCtD
Topiramate—Upset stomach—Metformin—polycystic ovary syndrome	0.00117	0.0297	CcSEcCtD
Topiramate—CYP3A4—urine—polycystic ovary syndrome	0.00104	0.0276	CbGeAlD
Topiramate—GRIA1—adipose tissue—polycystic ovary syndrome	0.000998	0.0265	CbGeAlD
Topiramate—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.000943	0.024	CcSEcCtD
Topiramate—Rigors—Metformin—polycystic ovary syndrome	0.000936	0.0238	CcSEcCtD
Topiramate—GRIA1—endocrine gland—polycystic ovary syndrome	0.000777	0.0206	CbGeAlD
Topiramate—Neuropathy—Metformin—polycystic ovary syndrome	0.000717	0.0183	CcSEcCtD
Topiramate—CA9—endocrine gland—polycystic ovary syndrome	0.000704	0.0187	CbGeAlD
Topiramate—Ear pain—Metformin—polycystic ovary syndrome	0.00065	0.0166	CcSEcCtD
Topiramate—GRIA2—endocrine gland—polycystic ovary syndrome	0.000617	0.0164	CbGeAlD
Topiramate—Nasal congestion—Metformin—polycystic ovary syndrome	0.000609	0.0155	CcSEcCtD
Topiramate—CA5B—adipose tissue—polycystic ovary syndrome	0.000601	0.016	CbGeAlD
Topiramate—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000568	0.0145	CcSEcCtD
Topiramate—GABRG2—pituitary gland—polycystic ovary syndrome	0.000566	0.015	CbGeAlD
Topiramate—Lethargy—Metformin—polycystic ovary syndrome	0.000566	0.0144	CcSEcCtD
Topiramate—GRIK2—endocrine gland—polycystic ovary syndrome	0.000557	0.0148	CbGeAlD
Topiramate—Pain in extremity—Metformin—polycystic ovary syndrome	0.000554	0.0141	CcSEcCtD
Topiramate—Migraine—Metformin—polycystic ovary syndrome	0.000546	0.0139	CcSEcCtD
Topiramate—CA5B—adrenal gland—polycystic ovary syndrome	0.000539	0.0143	CbGeAlD
Topiramate—CA1—adipose tissue—polycystic ovary syndrome	0.00053	0.0141	CbGeAlD
Topiramate—CA2—embryo—polycystic ovary syndrome	0.000521	0.0138	CbGeAlD
Topiramate—CA12—endocrine gland—polycystic ovary syndrome	0.000521	0.0138	CbGeAlD
Topiramate—Dehydration—Metformin—polycystic ovary syndrome	0.000516	0.0131	CcSEcCtD
Topiramate—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000512	0.013	CcSEcCtD
Topiramate—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000506	0.0129	CcSEcCtD
Topiramate—Breast disorder—Metformin—polycystic ovary syndrome	0.000501	0.0128	CcSEcCtD
Topiramate—CA5B—vagina—polycystic ovary syndrome	0.000499	0.0133	CbGeAlD
Topiramate—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000496	0.0126	CcSEcCtD
Topiramate—SCN5A—vagina—polycystic ovary syndrome	0.000484	0.0129	CbGeAlD
Topiramate—Abdominal distension—Metformin—polycystic ovary syndrome	0.000482	0.0123	CcSEcCtD
Topiramate—Pancreatitis—Metformin—polycystic ovary syndrome	0.00047	0.012	CcSEcCtD
Topiramate—CA5B—endocrine gland—polycystic ovary syndrome	0.000467	0.0124	CbGeAlD
Topiramate—Angina pectoris—Metformin—polycystic ovary syndrome	0.000467	0.0119	CcSEcCtD
Topiramate—Sweating increased—Metformin—polycystic ovary syndrome	0.000467	0.0119	CcSEcCtD
Topiramate—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000459	0.0117	CcSEcCtD
Topiramate—Neutropenia—Metformin—polycystic ovary syndrome	0.000448	0.0114	CcSEcCtD
Topiramate—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000445	0.0113	CcSEcCtD
Topiramate—Infestation—Metformin—polycystic ovary syndrome	0.000427	0.0109	CcSEcCtD
Topiramate—Infestation NOS—Metformin—polycystic ovary syndrome	0.000427	0.0109	CcSEcCtD
Topiramate—CA2—adrenal cortex—polycystic ovary syndrome	0.000427	0.0113	CbGeAlD
Topiramate—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000419	0.0107	CcSEcCtD
Topiramate—CA4—pituitary gland—polycystic ovary syndrome	0.000416	0.0111	CbGeAlD
Topiramate—CA4—adipose tissue—polycystic ovary syndrome	0.000415	0.011	CbGeAlD
Topiramate—CA1—endocrine gland—polycystic ovary syndrome	0.000413	0.011	CbGeAlD
Topiramate—Bradycardia—Metformin—polycystic ovary syndrome	0.00039	0.00995	CcSEcCtD
Topiramate—Rhinitis—Metformin—polycystic ovary syndrome	0.000385	0.0098	CcSEcCtD
Topiramate—Hepatitis—Metformin—polycystic ovary syndrome	0.000384	0.00977	CcSEcCtD
Topiramate—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000382	0.00972	CcSEcCtD
Topiramate—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000378	0.00963	CcSEcCtD
Topiramate—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000377	0.0096	CcSEcCtD
Topiramate—CA4—adrenal gland—polycystic ovary syndrome	0.000372	0.00988	CbGeAlD
Topiramate—Eye disorder—Metformin—polycystic ovary syndrome	0.000358	0.00913	CcSEcCtD
Topiramate—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000356	0.00907	CcSEcCtD
Topiramate—Flushing—Metformin—polycystic ovary syndrome	0.000356	0.00907	CcSEcCtD
Topiramate—Angiopathy—Metformin—polycystic ovary syndrome	0.000348	0.00887	CcSEcCtD
Topiramate—CA4—female gonad—polycystic ovary syndrome	0.000347	0.00921	CbGeAlD
Topiramate—Immune system disorder—Metformin—polycystic ovary syndrome	0.000346	0.00883	CcSEcCtD
Topiramate—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000346	0.00881	CcSEcCtD
Topiramate—CA2—pituitary gland—polycystic ovary syndrome	0.000345	0.00917	CbGeAlD
Topiramate—Chills—Metformin—polycystic ovary syndrome	0.000344	0.00877	CcSEcCtD
Topiramate—CA2—adipose tissue—polycystic ovary syndrome	0.000344	0.00913	CbGeAlD
Topiramate—Erythema—Metformin—polycystic ovary syndrome	0.000334	0.00851	CcSEcCtD
Topiramate—Malnutrition—Metformin—polycystic ovary syndrome	0.000334	0.00851	CcSEcCtD
Topiramate—Flatulence—Metformin—polycystic ovary syndrome	0.000329	0.00838	CcSEcCtD
Topiramate—Dysgeusia—Metformin—polycystic ovary syndrome	0.000327	0.00833	CcSEcCtD
Topiramate—CA4—endocrine gland—polycystic ovary syndrome	0.000322	0.00857	CbGeAlD
Topiramate—Muscle spasms—Metformin—polycystic ovary syndrome	0.000321	0.00818	CcSEcCtD
Topiramate—Vision blurred—Metformin—polycystic ovary syndrome	0.000315	0.00802	CcSEcCtD
Topiramate—Tremor—Metformin—polycystic ovary syndrome	0.000313	0.00797	CcSEcCtD
Topiramate—CYP2C19—vagina—polycystic ovary syndrome	0.000312	0.00828	CbGeAlD
Topiramate—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00031	0.00789	CcSEcCtD
Topiramate—CA2—adrenal gland—polycystic ovary syndrome	0.000308	0.00819	CbGeAlD
Topiramate—Malaise—Metformin—polycystic ovary syndrome	0.000301	0.00767	CcSEcCtD
Topiramate—Syncope—Metformin—polycystic ovary syndrome	0.000299	0.00763	CcSEcCtD
Topiramate—Palpitations—Metformin—polycystic ovary syndrome	0.000295	0.00752	CcSEcCtD
Topiramate—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000293	0.00748	CcSEcCtD
Topiramate—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000292	0.00775	CbGeAlD
Topiramate—Hypertension—Metformin—polycystic ovary syndrome	0.000288	0.00734	CcSEcCtD
Topiramate—CA2—female gonad—polycystic ovary syndrome	0.000287	0.00764	CbGeAlD
Topiramate—CA2—vagina—polycystic ovary syndrome	0.000286	0.00759	CbGeAlD
Topiramate—Chest pain—Metformin—polycystic ovary syndrome	0.000284	0.00724	CcSEcCtD
Topiramate—Myalgia—Metformin—polycystic ovary syndrome	0.000284	0.00724	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000282	0.00719	CcSEcCtD
Topiramate—Discomfort—Metformin—polycystic ovary syndrome	0.000281	0.00715	CcSEcCtD
Topiramate—Oedema—Metformin—polycystic ovary syndrome	0.000273	0.00694	CcSEcCtD
Topiramate—Infection—Metformin—polycystic ovary syndrome	0.000271	0.0069	CcSEcCtD
Topiramate—Shock—Metformin—polycystic ovary syndrome	0.000268	0.00683	CcSEcCtD
Topiramate—CA2—endocrine gland—polycystic ovary syndrome	0.000267	0.0071	CbGeAlD
Topiramate—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000267	0.00681	CcSEcCtD
Topiramate—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000267	0.0068	CcSEcCtD
Topiramate—Skin disorder—Metformin—polycystic ovary syndrome	0.000265	0.00674	CcSEcCtD
Topiramate—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000263	0.00671	CcSEcCtD
Topiramate—Anorexia—Metformin—polycystic ovary syndrome	0.00026	0.00662	CcSEcCtD
Topiramate—Hypotension—Metformin—polycystic ovary syndrome	0.000255	0.00649	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000248	0.00632	CcSEcCtD
Topiramate—Paraesthesia—Metformin—polycystic ovary syndrome	0.000245	0.00623	CcSEcCtD
Topiramate—Dyspnoea—Metformin—polycystic ovary syndrome	0.000243	0.00619	CcSEcCtD
Topiramate—Somnolence—Metformin—polycystic ovary syndrome	0.000242	0.00617	CcSEcCtD
Topiramate—Dyspepsia—Metformin—polycystic ovary syndrome	0.00024	0.00611	CcSEcCtD
Topiramate—Decreased appetite—Metformin—polycystic ovary syndrome	0.000237	0.00603	CcSEcCtD
Topiramate—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000235	0.00599	CcSEcCtD
Topiramate—Fatigue—Metformin—polycystic ovary syndrome	0.000235	0.00598	CcSEcCtD
Topiramate—Constipation—Metformin—polycystic ovary syndrome	0.000233	0.00594	CcSEcCtD
Topiramate—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000225	0.00572	CcSEcCtD
Topiramate—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000223	0.00568	CcSEcCtD
Topiramate—Urticaria—Metformin—polycystic ovary syndrome	0.000216	0.00551	CcSEcCtD
Topiramate—Abdominal pain—Metformin—polycystic ovary syndrome	0.000215	0.00549	CcSEcCtD
Topiramate—Asthenia—Metformin—polycystic ovary syndrome	0.000196	0.00498	CcSEcCtD
Topiramate—Pruritus—Metformin—polycystic ovary syndrome	0.000193	0.00491	CcSEcCtD
Topiramate—Diarrhoea—Metformin—polycystic ovary syndrome	0.000186	0.00475	CcSEcCtD
Topiramate—Dizziness—Metformin—polycystic ovary syndrome	0.00018	0.00459	CcSEcCtD
Topiramate—Vomiting—Metformin—polycystic ovary syndrome	0.000173	0.00441	CcSEcCtD
Topiramate—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000172	0.00458	CbGeAlD
Topiramate—Rash—Metformin—polycystic ovary syndrome	0.000172	0.00438	CcSEcCtD
Topiramate—Dermatitis—Metformin—polycystic ovary syndrome	0.000172	0.00437	CcSEcCtD
Topiramate—Headache—Metformin—polycystic ovary syndrome	0.000171	0.00435	CcSEcCtD
Topiramate—Nausea—Metformin—polycystic ovary syndrome	0.000162	0.00412	CcSEcCtD
Topiramate—CA4—Metabolism—RRM2—polycystic ovary syndrome	2.43e-05	0.000327	CbGpPWpGaD
Topiramate—CA7—Metabolism—TH—polycystic ovary syndrome	2.42e-05	0.000325	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TH—polycystic ovary syndrome	2.42e-05	0.000325	CbGpPWpGaD
Topiramate—CA2—Metabolism—SULT2A1—polycystic ovary syndrome	2.41e-05	0.000323	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.41e-05	0.000323	CbGpPWpGaD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	2.41e-05	0.000323	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	2.38e-05	0.00032	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP19A1—polycystic ovary syndrome	2.37e-05	0.000319	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP19A1—polycystic ovary syndrome	2.37e-05	0.000319	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SLC2A4—polycystic ovary syndrome	2.36e-05	0.000316	CbGpPWpGaD
Topiramate—CA7—Metabolism—SLC2A4—polycystic ovary syndrome	2.36e-05	0.000316	CbGpPWpGaD
Topiramate—CA4—Metabolism—YAP1—polycystic ovary syndrome	2.35e-05	0.000315	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	2.34e-05	0.000314	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	2.34e-05	0.000314	CbGpPWpGaD
Topiramate—CA2—Metabolism—RRM2—polycystic ovary syndrome	2.33e-05	0.000313	CbGpPWpGaD
Topiramate—CA9—Metabolism—LHB—polycystic ovary syndrome	2.33e-05	0.000313	CbGpPWpGaD
Topiramate—CA1—Metabolism—SULT2A1—polycystic ovary syndrome	2.31e-05	0.00031	CbGpPWpGaD
Topiramate—CA9—Metabolism—HSD3B2—polycystic ovary syndrome	2.28e-05	0.000306	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	2.26e-05	0.000303	CbGpPWpGaD
Topiramate—CA4—Metabolism—NAMPT—polycystic ovary syndrome	2.25e-05	0.000302	CbGpPWpGaD
Topiramate—CA2—Metabolism—YAP1—polycystic ovary syndrome	2.25e-05	0.000302	CbGpPWpGaD
Topiramate—CA12—Metabolism—TH—polycystic ovary syndrome	2.25e-05	0.000301	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.24e-05	0.0003	CbGpPWpGaD
Topiramate—CA1—Metabolism—RRM2—polycystic ovary syndrome	2.24e-05	0.0003	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP11A1—polycystic ovary syndrome	2.23e-05	0.000299	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP19A1—polycystic ovary syndrome	2.22e-05	0.000297	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP19A1—polycystic ovary syndrome	2.22e-05	0.000297	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKR1C1—polycystic ovary syndrome	2.21e-05	0.000296	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.2e-05	0.000296	CbGpPWpGaD
Topiramate—CA12—Metabolism—SLC2A4—polycystic ovary syndrome	2.18e-05	0.000293	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.17e-05	0.000291	CbGpPWpGaD
Topiramate—CA2—Metabolism—NAMPT—polycystic ovary syndrome	2.16e-05	0.00029	CbGpPWpGaD
Topiramate—CA1—Metabolism—YAP1—polycystic ovary syndrome	2.16e-05	0.000289	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	2.14e-05	0.000287	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.14e-05	0.000287	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	2.13e-05	0.000286	CbGpPWpGaD
Topiramate—CA6—Metabolism—GNAS—polycystic ovary syndrome	2.12e-05	0.000284	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GNAS—polycystic ovary syndrome	2.12e-05	0.000284	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKR1C3—polycystic ovary syndrome	2.1e-05	0.000282	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	2.09e-05	0.00028	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	2.07e-05	0.000278	CbGpPWpGaD
Topiramate—CA1—Metabolism—NAMPT—polycystic ovary syndrome	2.07e-05	0.000278	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	2.07e-05	0.000278	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP17A1—polycystic ovary syndrome	2.07e-05	0.000278	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	2.05e-05	0.000276	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.05e-05	0.000275	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.05e-05	0.000275	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP11A1—polycystic ovary syndrome	2.05e-05	0.000275	CbGpPWpGaD
Topiramate—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	2.03e-05	0.000272	CbGpPWpGaD
Topiramate—CA6—Metabolism—NCOR1—polycystic ovary syndrome	2.02e-05	0.000271	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NCOR1—polycystic ovary syndrome	2.02e-05	0.000271	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	2.02e-05	0.00027	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	2e-05	0.000268	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	1.98e-05	0.000266	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	1.98e-05	0.000266	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GNAS—polycystic ovary syndrome	1.98e-05	0.000265	CbGpPWpGaD
Topiramate—CA7—Metabolism—GNAS—polycystic ovary syndrome	1.98e-05	0.000265	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	1.98e-05	0.000265	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	1.97e-05	0.000265	CbGpPWpGaD
Topiramate—CA9—Metabolism—RRM2—polycystic ovary syndrome	1.97e-05	0.000264	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKR1C3—polycystic ovary syndrome	1.93e-05	0.000259	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.93e-05	0.000258	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	1.92e-05	0.000258	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000257	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	1.91e-05	0.000257	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP17A1—polycystic ovary syndrome	1.9e-05	0.000255	CbGpPWpGaD
Topiramate—CA9—Metabolism—YAP1—polycystic ovary syndrome	1.9e-05	0.000254	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	1.89e-05	0.000254	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NCOR1—polycystic ovary syndrome	1.88e-05	0.000253	CbGpPWpGaD
Topiramate—CA7—Metabolism—NCOR1—polycystic ovary syndrome	1.88e-05	0.000253	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.87e-05	0.000251	CbGpPWpGaD
Topiramate—CA12—Metabolism—GNAS—polycystic ovary syndrome	1.83e-05	0.000246	CbGpPWpGaD
Topiramate—CA9—Metabolism—NAMPT—polycystic ovary syndrome	1.82e-05	0.000244	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	1.82e-05	0.000244	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.81e-05	0.000242	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	1.8e-05	0.000241	CbGpPWpGaD
Topiramate—CA4—Metabolism—TH—polycystic ovary syndrome	1.79e-05	0.00024	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.79e-05	0.00024	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	1.79e-05	0.00024	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	1.79e-05	0.00024	CbGpPWpGaD
Topiramate—CA6—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	0.000239	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	1.78e-05	0.000239	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	1.77e-05	0.000238	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	1.75e-05	0.000234	CbGpPWpGaD
Topiramate—CA12—Metabolism—NCOR1—polycystic ovary syndrome	1.75e-05	0.000234	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.75e-05	0.000234	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	1.74e-05	0.000234	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.72e-05	0.000231	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	1.72e-05	0.000231	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.72e-05	0.000231	CbGpPWpGaD
Topiramate—CA2—Metabolism—TH—polycystic ovary syndrome	1.72e-05	0.00023	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	1.7e-05	0.000228	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	1.68e-05	0.000225	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	1.67e-05	0.000224	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	1.67e-05	0.000224	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-05	0.000223	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-05	0.000223	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	1.66e-05	0.000222	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	1.65e-05	0.000221	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	1.65e-05	0.000221	CbGpPWpGaD
Topiramate—CA1—Metabolism—TH—polycystic ovary syndrome	1.65e-05	0.000221	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	1.64e-05	0.000221	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	1.64e-05	0.00022	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.64e-05	0.00022	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	1.62e-05	0.000218	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	1.61e-05	0.000216	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	1.6e-05	0.000215	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	1.59e-05	0.000213	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.57e-05	0.000211	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	1.57e-05	0.000211	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—polycystic ovary syndrome	1.54e-05	0.000207	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	1.54e-05	0.000206	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	1.51e-05	0.000202	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	1.48e-05	0.000198	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	1.47e-05	0.000198	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	1.47e-05	0.000197	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNAS—polycystic ovary syndrome	1.46e-05	0.000196	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	1.46e-05	0.000195	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—polycystic ovary syndrome	1.45e-05	0.000194	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—polycystic ovary syndrome	1.45e-05	0.000194	CbGpPWpGaD
Topiramate—CA9—Metabolism—TH—polycystic ovary syndrome	1.45e-05	0.000194	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	1.43e-05	0.000192	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	1.43e-05	0.000192	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	1.43e-05	0.000192	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—polycystic ovary syndrome	1.43e-05	0.000191	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—polycystic ovary syndrome	1.43e-05	0.000191	CbGpPWpGaD
Topiramate—CA5A—Metabolism—INS—polycystic ovary syndrome	1.42e-05	0.00019	CbGpPWpGaD
Topiramate—CA6—Metabolism—INS—polycystic ovary syndrome	1.42e-05	0.00019	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	1.41e-05	0.000189	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	1.4e-05	0.000188	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	1.4e-05	0.000188	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNAS—polycystic ovary syndrome	1.4e-05	0.000188	CbGpPWpGaD
Topiramate—CA4—Metabolism—NCOR1—polycystic ovary syndrome	1.39e-05	0.000187	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.39e-05	0.000186	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.37e-05	0.000184	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—polycystic ovary syndrome	1.35e-05	0.000181	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—polycystic ovary syndrome	1.35e-05	0.000181	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNAS—polycystic ovary syndrome	1.34e-05	0.00018	CbGpPWpGaD
Topiramate—CA2—Metabolism—NCOR1—polycystic ovary syndrome	1.34e-05	0.000179	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—polycystic ovary syndrome	1.33e-05	0.000179	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—polycystic ovary syndrome	1.33e-05	0.000179	CbGpPWpGaD
Topiramate—CA5B—Metabolism—INS—polycystic ovary syndrome	1.32e-05	0.000178	CbGpPWpGaD
Topiramate—CA7—Metabolism—INS—polycystic ovary syndrome	1.32e-05	0.000178	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	1.32e-05	0.000178	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	1.32e-05	0.000177	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	1.31e-05	0.000175	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	1.3e-05	0.000175	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	1.3e-05	0.000175	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	1.28e-05	0.000172	CbGpPWpGaD
Topiramate—CA1—Metabolism—NCOR1—polycystic ovary syndrome	1.28e-05	0.000172	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.28e-05	0.000171	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	1.27e-05	0.00017	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—polycystic ovary syndrome	1.25e-05	0.000168	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—polycystic ovary syndrome	1.23e-05	0.000166	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—polycystic ovary syndrome	1.23e-05	0.000165	CbGpPWpGaD
Topiramate—CA12—Metabolism—INS—polycystic ovary syndrome	1.23e-05	0.000165	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	1.21e-05	0.000163	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.19e-05	0.00016	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.19e-05	0.00016	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNAS—polycystic ovary syndrome	1.18e-05	0.000158	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—polycystic ovary syndrome	1.18e-05	0.000158	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—polycystic ovary syndrome	1.13e-05	0.000152	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.13e-05	0.000152	CbGpPWpGaD
Topiramate—CA9—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	0.000151	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	1.11e-05	0.000149	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	1.11e-05	0.000149	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.07e-05	0.000143	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	0.000143	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.05e-05	0.000141	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.05e-05	0.000141	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	1.04e-05	0.000139	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.04e-05	0.000139	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	1.02e-05	0.000137	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	1.01e-05	0.000135	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—polycystic ovary syndrome	9.98e-06	0.000134	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—polycystic ovary syndrome	9.94e-06	0.000133	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—polycystic ovary syndrome	9.84e-06	0.000132	CbGpPWpGaD
Topiramate—CA4—Metabolism—INS—polycystic ovary syndrome	9.79e-06	0.000131	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—polycystic ovary syndrome	9.57e-06	0.000128	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—polycystic ovary syndrome	9.44e-06	0.000127	CbGpPWpGaD
Topiramate—CA2—Metabolism—INS—polycystic ovary syndrome	9.38e-06	0.000126	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	9.31e-06	0.000125	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	9.24e-06	0.000124	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—polycystic ovary syndrome	9.17e-06	0.000123	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—polycystic ovary syndrome	9.05e-06	0.000121	CbGpPWpGaD
Topiramate—CA1—Metabolism—INS—polycystic ovary syndrome	9e-06	0.000121	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	8.82e-06	0.000118	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.45e-06	0.000113	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.45e-06	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	8.42e-06	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.32e-06	0.000112	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—polycystic ovary syndrome	8.06e-06	0.000108	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—polycystic ovary syndrome	7.95e-06	0.000107	CbGpPWpGaD
Topiramate—CA9—Metabolism—INS—polycystic ovary syndrome	7.91e-06	0.000106	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	7.85e-06	0.000105	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.83e-06	0.000105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	7.5e-06	0.000101	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	7.18e-06	9.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	7.16e-06	9.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.07e-06	9.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.71e-06	9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.68e-06	8.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.68e-06	8.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.53e-06	8.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	6.38e-06	8.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	6.18e-06	8.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.68e-06	7.63e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.6e-06	7.51e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.51e-06	7.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	5.31e-06	7.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.3e-06	7.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	5.1e-06	6.84e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.07e-06	6.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.06e-06	6.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	5.04e-06	6.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5e-06	6.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.76e-06	6.38e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.68e-06	6.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.51e-06	6.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.3e-06	5.77e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.05e-06	5.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.94e-06	5.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.92e-06	5.26e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.84e-06	5.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.71e-06	4.98e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.7e-06	4.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.42e-06	4.59e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.31e-06	4.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.31e-06	4.44e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.19e-06	4.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.15e-06	4.23e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.07e-06	4.11e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.03e-06	4.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.99e-06	4.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.86e-06	3.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.82e-06	3.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.78e-06	3.74e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.44e-06	3.27e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.37e-06	3.18e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.26e-06	3.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.23e-06	2.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.23e-06	2.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.21e-06	2.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.99e-06	2.67e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.89e-06	2.54e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.8e-06	2.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.67e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.36e-06	1.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.34e-06	1.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.33e-06	1.79e-05	CbGpPWpGaD
